Seres Therapeutics Inc. (MCRB) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Seres Therapeutics Inc.

    NASDAQ: MCRB · Real-Time Price · USD
    18.93
    0.03 (0.16%)
    At close: Sep 26, 2025, 3:59 PM
    18.93
    0.00%
    After-hours: Sep 26, 2025, 04:10 PM EDT

    Seres Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 18.99K -31.52 -48.39 -11.65
    PEG Ratio
    		 -189.72 0.51 0.58 -0.01
    PS Ratio
    		 n/a 28.37 1.7K 5.27
    PB Ratio
    		 187.37 -79.9 1.12K 5.81
    P/FCF Ratio
    		 -17.34 -28.6 -50.72 -265.42
    P/OCF Ratio
    		 -17.38 -30.54 -52.9 114.22
    OCF/S Ratio
    		 n/a -0.93 -32.1 0.05
    Debt / Equity Ratio
    		 6.65 -4.77 15.08 0.37
    Quick Ratio
    		 0.94 1.48 2.28 3.69
    Current Ratio
    		 0.94 1.78 2.28 3.69
    Asset Turnover
    		 n/a 0.35 0.02 0.41
    Interest Coverage
    		 n/a -8.2 -40.95 -22.16
    Return on Equity
    		 0.01 2.54 -23.2 -0.5
    Return on Assets
    		 n/a -0.32 -0.72 -0.18
    Return on Invested Capital
    		 -1.05 -0.4 -0.94 -0.21
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a 0.99 0.86 1.00
    Net Profit Margin
    		 n/a -0.9 -35.09 -0.45
    Pretax Profit Margin
    		 n/a -0.9 -35.09 -0.45
    Operating Profit Margin
    		 n/a -0.85 -34.58 -0.45
    FCF Margin
    		 n/a -0.99 -33.48 -0.02
    EBITDA Margin
    		 n/a -0.75 -33.32 -0.39

    Add to Watchlist